It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

In this GEN webinar, Jeremy Tomlinson, PhD, will discuss the pathogenesis of MASLD, share examples from recent research that ...

Papillary carcinoma of the breast, also known as intraductal papillary carcinoma, is a rare type of breast cancer that accounts for only 0.5% of all new cases of invasive breast cancers. Under a ...

Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information in this primary liver cancer section is mostly about ...

Chronic liver disease can be associated with liver cancer although some types, such as the rare fibrolamellar-hepatocellular carcinoma (FLL-HCC), occur in younger people with no history of a liver ...

Survival rates for patients with hepatocellular carcinoma (HCC) have improved, but overall survival remains low. Early detection and treatment significantly enhanced survival outcomes between ...

Our aim was therefore to investigate whether there is a sex difference in the pathogenesis and management of dyslipidemia ... Fatty acids; HCC, hepatocellular carcinoma; HDL-C, high-density ...

One subtype in particular, hepatocellular carcinoma (HCC), accounts for 80 ... laboratory will enable a better understanding of HCC pathogenesis. It will also be very useful for testing new ...

This study provides useful data substantiating a role of long noncoding RNAs in liver metabolism and organismal physiology. With murine knockout and knockin models, the authors invoke a previously ...